Orgentec Diagnostika

Mainz, Germany Founded: 2009 • Age: 17 yrs Acquired By Sebia
Diagnostics tools for Autoimmune and Infectious Diseases

About Orgentec Diagnostika

Orgentec Diagnostika is a Healthcare company based in Mainz (Germany) founded in 2009, and was acquired by Sebia in July 2020. Diagnostics tools for Autoimmune and Infectious Diseases. Orgentec Diagnostika has completed 1 acquisition, including Corgenix. Its chief executive, as recorded, is James Widergren. Its website orgentec.com draws about 14 thousand monthly visits. Orgentec Diagnostika offers products and services including Alegria, ELISA, and Immunfluoreszenz. Its focus areas include Diversified Diagnostics. Its legal entity is ORGENTEC Diagnostika GmbH.

Company details

ORGENTEC develops, manufactures and markets in-vitro diagnostic products for clinical labs. The company offers more than 200 highly specific ELISA test systems, blot and immunofluorescence tests for the diagnosis of Autoimmune and Infectious Diseases. In addition, the company offers fully automatic analyzer Alegria, stool diagnostic products (Alpha-1-Antitrypsin test, Calprotectin test, lactoferrin test, Stool Extraction medium, Stool Extraction Tubes, and Stool Sample Collector) and 25-OH vitamin D 3 D 2 ELISA test. Its rapid test rheumachec is a lateral flow test that allows detection of combined rheumatoid factors (RF) and autoantibodies against mutated citrullinated vimentin (anti-MCV ) in a whole blood sample.

Operational Areas
Key Metrics
  • Latest Funding Round
    $392.96 (USD), Grant

    Feb 2017

  • Investors
    Sebia

    & 2 more

  • Investments & Acquisitions
  • Acquired by
    Sebia

    (Jul 2020)

Products & Services of Orgentec Diagnostika

Orgentec Diagnostika offers a comprehensive portfolio of products and services, including Alegria, ELISA, and Immunfluoreszenz.

Alegria
Diagnostic Platform

System for testing autoimmune and infectious diseases in laboratories

ELISA
Diagnostic Test

Assay method for detecting antibodies in infectious and autoimmune conditions

Immunfluoreszenz
Diagnostic Technique

Fluorescence-based method for identifying disease markers in diagnostics

Apps and channels of Orgentec Diagnostika

its YouTube channel ORGENTECMainz has 1.03K subscribers and 4 videos.

ORGENTECMainz
YouTube 1.03K subscribers 4 videos Science & Technology
Open channel

Videos from Orgentec Diagnostika

The most watched videos on Orgentec Diagnostika's YouTube channel, ORGENTECMainz (1.03K subscribers). Click a video to play it here.

ELISA Test Systems in Autoimmune Disease Diagnostics (Autoimmunity)
183.4K views
ELISA-Testsysteme in der Autoimmundiagnostik (Autoimmunität)
33.5K views
Immunoblot Test Systems: Laboratory Assays for Diagnosing Autoimmune Diseases (Autoimmunity)
33.3K views
Immunoblot-Testsysteme für die Autoimmundiagnostik: Labornachweis autoimmuner Erkrankungen
6.9K views

More on ORGENTECMainz.

Funding Insights of Orgentec Diagnostika

  • Total Rounds 3
  • Last Round Grant — $393
  • Investors Count 2

All 3 funding rounds of Orgentec Diagnostika with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2017$393Grant––
May 2014Private Equity Round––
Jan 2014Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Orgentec Diagnostika

Orgentec Diagnostika has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sebia, European Union and Water Street.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Water Street is engaged in strategic investments in healthcare sectors.
2005waterstreet.comChicago, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Electrophoresis-based in vitro diagnostics products are developed and provided.
1967sebia.comEvry Courcouronnes, France
Premium access

Investor details for Orgentec Diagnostika

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Orgentec Diagnostika

5 people are tracked at Orgentec Diagnostika (3 in leadership, 2 in team).

NameRoleGroup
James Widergren
CEO & PresidentLeadership
Michael Funk
Finance DirectorLeadership
Johanna Galinski
Head Of Commercial Finance/commercial OperationsLeadership
Dr. Gernot Brasen
Project Lead Instrument DevelopmentTeam
Dr. Natalia Kuzmina
Area Manager Eastern Europe & Central AsiaTeam
Premium access

Complete people profiles for Orgentec Diagnostika

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Orgentec Diagnostika

Orgentec Diagnostika has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Corgenix.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diagnostic tests for vascular diseases are developed and supplied.
corgenix.comBroomfield, United States1990Aug 2014$16M
Premium access

Complete acquisition details for Orgentec Diagnostika

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Orgentec Diagnostika

5 dated milestones of Orgentec Diagnostika across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Orgentec Diagnostika is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Corgenix.
  4. Funding Latest funding round, Grant, of $393.
  5. Exit Acquired by Sebia.

Web traffic of Orgentec Diagnostika

The website of Orgentec Diagnostika (orgentec.com) receives about 13.9K visits a month.

  • Monthly visits
    13.9K

    ▼ 30.1% vs previous month

Similar websites

Websites whose visitors overlap most with Orgentec Diagnostika. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
labor-duesseldorf.de
labor-duesseldorf.de
100%
#2,169,151–
fennerlabor.de
fennerlabor.de
93%
#1,728,244–
inovadx.com
78%
View details
trinitybiotech.com
77%
9.3K#2,475,266View details
hemagen.com
75%
View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 19 similar websites and full traffic analytics for Orgentec Diagnostika

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Orgentec Diagnostika

Premium access

Complete news archive for Orgentec Diagnostika

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orgentec Diagnostika

Orgentec Diagnostika was founded in 2009 and raised its 1st funding round 5 years after it was founded.

Orgentec Diagnostika is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.

James Widergren is the CEO of Orgentec Diagnostika, as recorded in our data.

ORGENTEC develops, manufactures and markets in-vitro diagnostic products for clinical labs. The company offers more than 200 highly specific ELISA test systems, blot and immunofluorescence tests for the diagnosis of Autoimmune and Infectious Diseases. In addition, the company offers fully automatic analyzer Alegria, stool diagnostic products (Alpha-1-Antitrypsin test, Calprotectin test, lactoferrin test, Stool Extraction medium, Stool Extraction Tubes, and Stool Sample Collector) and 25-OH vitamin D 3 D 2 ELISA test. Its rapid test rheumachec is a lateral flow test that allows detection of combined rheumatoid factors (RF) and autoantibodies against mutated citrullinated vimentin (anti-MCV ) in a whole blood sample.

Orgentec Diagnostika offers Alegria, ELISA, and Immunfluoreszenz.

Orgentec Diagnostika has made 1 acquisition, including Corgenix.

Orgentec Diagnostika has 3 investors. Key investors include Sebia, European Union, and Water Street.

Orgentec Diagnostika operates through Orgentec Diagnostika Gmbh.

Yes. Orgentec Diagnostika was acquired by Sebia in July 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available